China Pharma Holdings Stock Overlap Studies MAVP
| CPHI Stock | USD 0.20 0.01 5.26% |
| Symbol |
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.
China Pharma Technical Analysis Modules
Most technical analysis of China Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for China from various momentum indicators to cycle indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About China Pharma Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of China Pharma Holdings. We use our internally-developed statistical techniques to arrive at the intrinsic value of China Pharma Holdings based on widely used predictive technical indicators. In general, we focus on analyzing China Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build China Pharma's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of China Pharma's intrinsic value. In addition to deriving basic predictive indicators for China Pharma, we also check how macroeconomic factors affect China Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Dividend Yield | 0.002105 | 0.00187 | Price To Sales Ratio | 0.29 | 0.28 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Pharma's short interest history, or implied volatility extrapolated from China Pharma options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Gambling Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Business Services Invested over 100 shares | |
 | Banking Invested over 20 shares | |
 | SRI Sustainable Growth Invested few shares | |
 | Adviser Favorites Invested few shares | |
 | Momentum Invested over 50 shares | |
 | Chemicals Invested over 30 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Warren Buffett Holdings Invested over 60 shares | |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Pharma Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China Pharma. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.69) | Revenue Per Share 0.63 | Quarterly Revenue Growth (0.16) | Return On Assets (0.18) | Return On Equity (0.75) |
The market value of China Pharma Holdings is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China Pharma's value that differs from its market value or its book value, called intrinsic value, which is China Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China Pharma's market value can be influenced by many factors that don't directly affect China Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if China Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.